Genomic Analysis: Steering Clinical Trials from thescientistllc on Vimeo.

Genotyping during the active study phase of clinical trials is becoming more popular because of lower costs and the availability of high-throughput microarray platforms that quickly provide accurate results. During oncology clinical trials, genomics data enable better patient stratification, optimized study results, and well-planned study designs. In this webinar brought to you by The Scientist, our panel of experts will discuss the current state and future direction of genomic analysis in oncology clinical trials.

Topics to be Covered:

  • Pros and cons of biomarker-based patient selection versus biomarker discovery in clinical trials
  • Breast cancer precision medicine: the right drug for the right patient at the right time

Meet the Speakers:

Lajos Pusztai, MD, DPhil
Professor of Medicine (Medical Oncology)
Breast Medical Oncology Group
Yale School of Medicine

Laura J. van 't Veer, PhD
Leader, Breast Oncology Program
Director, Applied Genomics...

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?